Athens Medical C.S.A. (ATH:IATR)

Market Cap	153.52M
Revenue (ttm)	269.85M
Net Income (ttm)	1.78M
Shares Out	86.74M
EPS (ttm)	0.02
PE Ratio	86.30
Forward PE	n/a
Dividend	0.02 (1.13%)
Ex-Dividend Date	Jul 22, 2024

Volume	7,283
Average Volume	4,977
Open	1.760
Previous Close	1.750
Day's Range	1.710 - 1.780
52-Week Range	1.440 - 2.120
Beta	1.06
RSI	53.55
Earnings Date	Jun 27, 2025

About Athens Medical C.S.A.

Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and neuro- and spine surgery services. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoul...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1983
• Employees: 3,495
• Stock Exchange: Athens Stock Exchange
• Ticker Symbol: IATR

Financial Performance

In 2024, Athens Medical C.S.A.'s revenue was 269.85 million, an increase of 4.44% compared to the previous year's 258.36 million. Earnings were 1.78 million, a decrease of -77.99%.